Black Bird Biotech, Inc.

OTCPK:BBBT Stock Report

Market Cap: US$3.7k

Black Bird Biotech Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Nelson Grist

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure3.8yrs
Board average tenure4.9yrs

Recent management updates

Recent updates

CEO

Nelson Grist

less than a year

Tenure

Mr. Nelson Grist is Chief Executive Officer of Black Bird Biotech, Inc. from April 2024. He has years of experience in executive positions at publicly traded companies focused on emerging technologies in a...

Leadership Team

NamePositionTenureCompensationOwnership
Fabian Deneault
Chairman of the Board & President4.9yrsUS$90.00kno data
William Sluss
CFO, VP of Finance & Director4.9yrsUS$60.00kno data
Eric Newlan
VP, Secretary & Directorno dataUS$80.00kno data
Nelson Grist
Chief Executive Officerless than a yearno datano data
William LoBell
Executive Vice President of Sales & Development2.7yrsno data0.040%
$ 1.5

3.8yrs

Average Tenure

65.5yo

Average Age

Experienced Management: BBBT's management team is considered experienced (3.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Fabian Deneault
Chairman of the Board & President4.9yrsUS$90.00kno data
William Sluss
CFO, VP of Finance & Director4.9yrsUS$60.00kno data
Eric Newlan
VP, Secretary & Director4.9yrsUS$80.00kno data
Jie Qin
Director14.8yrsno datano data
L. Newlan
Director4.9yrsno datano data

4.9yrs

Average Tenure

64yo

Average Age

Experienced Board: BBBT's board of directors are considered experienced (4.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 13:26
End of Day Share Price 2024/12/20 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Black Bird Biotech, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution